Literature DB >> 26354776

Immunosuppression associated with chronic inflammation in the tumor microenvironment.

Dingzhi Wang1, Raymond N DuBois2.   

Abstract

Chronic inflammation contributes to cancer development via multiple mechanisms. One potential mechanism is that chronic inflammation can generate an immunosuppressive microenvironment that allows advantages for tumor formation and progression. The immunosuppressive environment in certain chronic inflammatory diseases and solid cancers is characterized by accumulation of proinflammatory mediators, infiltration of immune suppressor cells and activation of immune checkpoint pathways in effector T cells. In this review, we highlight recent advances in our understanding of how immunosuppression contributes to cancer and how proinflammatory mediators induce the immunosuppressive microenvironment via induction of immunosuppressive cells and activation of immune checkpoint pathways.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2015        PMID: 26354776      PMCID: PMC5006153          DOI: 10.1093/carcin/bgv123

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  125 in total

1.  Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection.

Authors:  Kathleen M Anderson; Steven J Czinn; Raymond W Redline; Thomas G Blanchard
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

Review 2.  New insights into chronic inflammation-induced immunosuppression.

Authors:  Julia Kanterman; Moshe Sade-Feldman; Michal Baniyash
Journal:  Semin Cancer Biol       Date:  2012-02-24       Impact factor: 15.707

3.  Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity.

Authors:  Masako Nakanishi; Antoine Menoret; Takuji Tanaka; Shingo Miyamoto; David C Montrose; Anthony T Vella; Daniel W Rosenberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-05-16

4.  Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies.

Authors:  Austin Duffy; Fei Zhao; Lydia Haile; Jaba Gamrekelashvili; Suzanne Fioravanti; Chi Ma; Tamar Kapanadze; Kathryn Compton; William D Figg; Tim F Greten
Journal:  Cancer Immunol Immunother       Date:  2012-08-22       Impact factor: 6.968

5.  Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.

Authors:  Wei Tan; Weizhou Zhang; Amy Strasner; Sergei Grivennikov; Jin Q Cheng; Robert M Hoffman; Michael Karin
Journal:  Nature       Date:  2011-02-16       Impact factor: 49.962

Review 6.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression.

Authors:  Sabine Mumprecht; Christian Schürch; Juerg Schwaller; Max Solenthaler; Adrian F Ochsenbein
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

8.  Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.

Authors:  Mojgan Ahmadzadeh; Laura A Johnson; Bianca Heemskerk; John R Wunderlich; Mark E Dudley; Donald E White; Steven A Rosenberg
Journal:  Blood       Date:  2009-05-07       Impact factor: 22.113

9.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

Review 10.  Checkpoint blocking antibodies in cancer immunotherapy.

Authors:  Chrisann Kyi; Michael A Postow
Journal:  FEBS Lett       Date:  2013-10-23       Impact factor: 4.124

View more
  105 in total

1.  Thoracic Aorta Calcification and Noncardiovascular Disease-Related Mortality.

Authors:  Isac C Thomas; Caroline A Thompson; Mingan Yang; Matthew A Allison; Nketi I Forbang; Erin D Michos; Robyn L McClelland; Matthew J Budoff; Michael H Criqui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

2.  Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape.

Authors:  Li Wenbo; Jin Wang
Journal:  J R Soc Interface       Date:  2017-06       Impact factor: 4.118

3.  Green lipped mussel oil complex suppresses lipopolysaccharide stimulated inflammation via regulating nuclear factor-κB and mitogen activated protein kinases signaling in RAW264.7 murine macrophages.

Authors:  Jing Chen; Cheng Bao; Se Haeng Cho; Hong Jin Lee
Journal:  Food Sci Biotechnol       Date:  2017-06-08       Impact factor: 2.391

Review 4.  Complex interplay between tumor microenvironment and cancer therapy.

Authors:  Minhong Shen; Yibin Kang
Journal:  Front Med       Date:  2018-08-10       Impact factor: 4.592

5.  Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.

Authors:  Shadi Ferdosi; Douglas S Rehder; Paul Maranian; Erik P Castle; Thai H Ho; Harvey I Pass; Daniel W Cramer; Karen S Anderson; Lei Fu; David E C Cole; Tao Le; Xifeng Wu; Chad R Borges
Journal:  J Proteome Res       Date:  2017-11-21       Impact factor: 4.466

6.  Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinoma.

Authors:  Kathryn E Royse; Liang Chen; David H Berger; Michael M Ittmann; Hashem B El-Serag; Courtney J Balentine; David Y Graham; Peter A Richardson; Rolando E Rumbaut; Xiaoyun Shen; Donna L White; Li Jiao
Journal:  Int J Mol Epidemiol Genet       Date:  2017-04-15

Review 7.  NRF2 as a regulator of cell metabolism and inflammation in cancer.

Authors:  Feng He; Laura Antonucci; Michael Karin
Journal:  Carcinogenesis       Date:  2020-06-17       Impact factor: 4.944

8.  The Role of Prostaglandin E(2) in Tumor-Associated Immunosuppression.

Authors:  Dingzhi Wang; Raymond N DuBois
Journal:  Trends Mol Med       Date:  2015-12-17       Impact factor: 11.951

Review 9.  Long-term Consequences of the Acute Neural-Inflammatory Stress Response in the Cancer Surgical Patient: New Findings and Perspectives.

Authors:  Bernhard Riedel; Erica Sloan; Patrice Forget
Journal:  Int Anesthesiol Clin       Date:  2016

Review 10.  The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.

Authors:  Nick van Dijk; Samuel A Funt; Christian U Blank; Thomas Powles; Jonathan E Rosenberg; Michiel S van der Heijden
Journal:  Eur Urol       Date:  2018-09-28       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.